Cargando…
Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study
BACKGROUND: Randomized controlled trials (RCTs) demonstrated efficacy and safety of endovascular treatment (ET) in anterior circulation large vessel occlusions (LVO). We aimed at investigating how stroke patients treated by thrombectomy in clinical practice and their outcome compare to cohorts and r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059360/ https://www.ncbi.nlm.nih.gov/pubmed/32138684 http://dx.doi.org/10.1186/s12883-020-01653-z |
_version_ | 1783504034380906496 |
---|---|
author | Deb-Chatterji, Milani Pinnschmidt, Hans Flottmann, Fabian Leischner, Hannes Alegiani, Anna Brekenfeld, Caspar Fiehler, Jens Gerloff, Christian Thomalla, Götz |
author_facet | Deb-Chatterji, Milani Pinnschmidt, Hans Flottmann, Fabian Leischner, Hannes Alegiani, Anna Brekenfeld, Caspar Fiehler, Jens Gerloff, Christian Thomalla, Götz |
author_sort | Deb-Chatterji, Milani |
collection | PubMed |
description | BACKGROUND: Randomized controlled trials (RCTs) demonstrated efficacy and safety of endovascular treatment (ET) in anterior circulation large vessel occlusions (LVO). We aimed at investigating how stroke patients treated by thrombectomy in clinical practice and their outcome compare to cohorts and results of thrombectomy trials. METHODS: In a prospective study, we consecutively included stroke patients treated by thrombectomy (2015–2017). Baseline characteristics, procedural and outcome data were analyzed. Outcome was assessed by modified Rankin Scale (mRS) at 90 days. Ordinal regression analysis was performed to identify predictors of outcome. RESULTS: Thrombectomy was applied in 264 patients (median 75 years, 49.6% female). Median baseline National Institutes of Health Stroke Scale (NIHSS) was 16, 58.0% received concomitant intravenous thrombolysis, 62.1% were referred from external hospitals. Median Alberta Stroke Program Early CT Score (ASPECTS) was 7. Successful recanalization (modified Thrombolysis in Cerebral Infarction Score, mTICI 2b/3) was achieved in 72.0%. Symptomatic intracranial hemorrhage (sICH) occurred in 4.5%. Independent outcome (mRS 0–2) was achieved in 26.2%, poor outcome (mRS 5–6) in 49.2%. Only 33.5% met the stringent enrolment criteria of previous RCTs. Lower age, baseline NIHSS, pre-stroke mRS, higher ASPECTS, and successful recanalization were independent predictors of favourable outcome. CONCLUSIONS: The majority of stroke patients treated by ET in clinical practice would not have qualified for randomization in prior RCTs. Outcome in real-life patient cohorts is worse than in the highly selected cohorts from randomized trials, while rates of successful recanalization, sICH and outcome predictors are the same. Our findings support ET in broader patient populations than in the RCTs and may improve treatment decision in individual stroke patients with LVO in clinical practice. |
format | Online Article Text |
id | pubmed-7059360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70593602020-03-12 Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study Deb-Chatterji, Milani Pinnschmidt, Hans Flottmann, Fabian Leischner, Hannes Alegiani, Anna Brekenfeld, Caspar Fiehler, Jens Gerloff, Christian Thomalla, Götz BMC Neurol Research Article BACKGROUND: Randomized controlled trials (RCTs) demonstrated efficacy and safety of endovascular treatment (ET) in anterior circulation large vessel occlusions (LVO). We aimed at investigating how stroke patients treated by thrombectomy in clinical practice and their outcome compare to cohorts and results of thrombectomy trials. METHODS: In a prospective study, we consecutively included stroke patients treated by thrombectomy (2015–2017). Baseline characteristics, procedural and outcome data were analyzed. Outcome was assessed by modified Rankin Scale (mRS) at 90 days. Ordinal regression analysis was performed to identify predictors of outcome. RESULTS: Thrombectomy was applied in 264 patients (median 75 years, 49.6% female). Median baseline National Institutes of Health Stroke Scale (NIHSS) was 16, 58.0% received concomitant intravenous thrombolysis, 62.1% were referred from external hospitals. Median Alberta Stroke Program Early CT Score (ASPECTS) was 7. Successful recanalization (modified Thrombolysis in Cerebral Infarction Score, mTICI 2b/3) was achieved in 72.0%. Symptomatic intracranial hemorrhage (sICH) occurred in 4.5%. Independent outcome (mRS 0–2) was achieved in 26.2%, poor outcome (mRS 5–6) in 49.2%. Only 33.5% met the stringent enrolment criteria of previous RCTs. Lower age, baseline NIHSS, pre-stroke mRS, higher ASPECTS, and successful recanalization were independent predictors of favourable outcome. CONCLUSIONS: The majority of stroke patients treated by ET in clinical practice would not have qualified for randomization in prior RCTs. Outcome in real-life patient cohorts is worse than in the highly selected cohorts from randomized trials, while rates of successful recanalization, sICH and outcome predictors are the same. Our findings support ET in broader patient populations than in the RCTs and may improve treatment decision in individual stroke patients with LVO in clinical practice. BioMed Central 2020-03-05 /pmc/articles/PMC7059360/ /pubmed/32138684 http://dx.doi.org/10.1186/s12883-020-01653-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Deb-Chatterji, Milani Pinnschmidt, Hans Flottmann, Fabian Leischner, Hannes Alegiani, Anna Brekenfeld, Caspar Fiehler, Jens Gerloff, Christian Thomalla, Götz Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study |
title | Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study |
title_full | Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study |
title_fullStr | Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study |
title_full_unstemmed | Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study |
title_short | Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study |
title_sort | stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059360/ https://www.ncbi.nlm.nih.gov/pubmed/32138684 http://dx.doi.org/10.1186/s12883-020-01653-z |
work_keys_str_mv | AT debchatterjimilani strokepatientstreatedbythrombectomyinreallifedifferfromcohortsoftheclinicaltrialsaprospectiveobservationalstudy AT pinnschmidthans strokepatientstreatedbythrombectomyinreallifedifferfromcohortsoftheclinicaltrialsaprospectiveobservationalstudy AT flottmannfabian strokepatientstreatedbythrombectomyinreallifedifferfromcohortsoftheclinicaltrialsaprospectiveobservationalstudy AT leischnerhannes strokepatientstreatedbythrombectomyinreallifedifferfromcohortsoftheclinicaltrialsaprospectiveobservationalstudy AT alegianianna strokepatientstreatedbythrombectomyinreallifedifferfromcohortsoftheclinicaltrialsaprospectiveobservationalstudy AT brekenfeldcaspar strokepatientstreatedbythrombectomyinreallifedifferfromcohortsoftheclinicaltrialsaprospectiveobservationalstudy AT fiehlerjens strokepatientstreatedbythrombectomyinreallifedifferfromcohortsoftheclinicaltrialsaprospectiveobservationalstudy AT gerloffchristian strokepatientstreatedbythrombectomyinreallifedifferfromcohortsoftheclinicaltrialsaprospectiveobservationalstudy AT thomallagotz strokepatientstreatedbythrombectomyinreallifedifferfromcohortsoftheclinicaltrialsaprospectiveobservationalstudy |